Keramed distribution rights

Ziemer Ophthalmic Systems AG has announced that it has obtained exclusive rights for distribution in Germany, Switzerland and Austria of the KeraKlear artificial cornea and the EndoInjector from Keramed Inc, Sunnyvale, California. The KeraKlear Artificial Cornea is a medical device for the treatment of corneal blindness which can be implanted in the eye through a very small incision. The EndoInjector (previously known as the EndoShield) is the latest generation device to enable delivery of a corneal graft for Descemet's Stripping Endothelial Keratoplasty (DSEK). 'The KeraKlear Artificial Cornea and EndoInjector have CE approval. No regulatory clearance is available for either product in the US. Market introduction of both products in Germany, Switzerland and Austria is scheduled for autumn 2012,' said a company spokeswoman. Â
Latest Articles
ESCRS Today 2025: Happy Anniversaries!
ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.
ESCRS Today 2025: A Congress for Everyone
From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.
Beyond the Numbers
Empowering patient participation fosters continuous innovation in cataract surgery.
Thinking Beyond the Surgery Room
Practice management workshop focuses on financial operations and AI business applications.
Aid Cuts Threaten Global Eye Care Progress
USAID closure leads retreat in development assistance.
Supplement: ESCRS Clinical Trends Series: Presbyopia
Debate: FS-LASIK or KLEx for Hyperopia?
FS-LASIK has more of a track record, but KLEx offers advantages.
Four AI Applications Ready for Practice
Commercial offerings may save time, improve practice and research.
Perioperative Medication Regimens for Cataract Surgery
Randomised controlled clinical trial results provide evidence-based guidance.